These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1867662)

  • 1. [Comparison of the bioequivalence of two allopurinol preparations].
    Bührens K; Berndt P; Hilgenstock CM; Baumann W; Janzen D
    Arzneimittelforschung; 1991 Mar; 41(3):250-3. PubMed ID: 1867662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The bioequivalence of a new allopurinol tablet formulation in comparison to a reference formulation].
    Metzner JE; Buchberger D; Läuter J; Pech R
    Arzneimittelforschung; 1997 Nov; 47(11):1236-41. PubMed ID: 9463301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioequivalence of allopurinol-containing tablet preparations.
    Barthel W; Hüller G; Haustein KO
    Int J Clin Pharmacol Ther; 1999 Mar; 37(3):148-52. PubMed ID: 10190763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bioequivalence of a new tablet formulation of sotalol hydrochloride in comparison to a standard preparations].
    Herrmann R; Kleinbloesem CH
    Arzneimittelforschung; 1994 May; 44(5):589-92. PubMed ID: 8024627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bioequivalence of an optimized doxycycline preparation].
    Lode H; Deppermann N; Schmidt U
    Arzneimittelforschung; 1989 Sep; 39(9):1162-5. PubMed ID: 2590269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioequivalence of allopurinol and its metabolite oxipurinol in two tablet formulations.
    Guerra P; Frias J; Ruiz B; Soto A; Carcas A; Govantes C; Montuenga C; Fernández A
    J Clin Pharm Ther; 2001 Apr; 26(2):113-9. PubMed ID: 11350534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Testing of bioequivalence of a new sotalol hydrochloride preparation in comparison to a standard formulation].
    Herrmann R; Kleinbloesem CH
    Arzneimittelforschung; 1995 Aug; 45(8):849-52. PubMed ID: 7575745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioequivalence of allopurinol preparations: to be assessed by the parent drug or the active metabolite?
    Walter-Sack I; de Vries JX; Kreiner C; Ittensohn A; Stenzhorn G; Voss A; Weber E
    Clin Investig; 1993 Mar; 71(3):240-6. PubMed ID: 8481628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relative bioavailability of paracetamol in suppositories preparations in comparison to tablets].
    Blume H; Ali SL; Elze M; Krämer J; Wendt G; Scholz ME
    Arzneimittelforschung; 1994 Dec; 44(12):1333-8. PubMed ID: 7848353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics and bioequivalence of two ibuprofen formulations].
    Lenhard G; Kieferndorf U; Berner G; Engels B; Vögtle-Junkert U
    Arzneimittelforschung; 1990 Dec; 40(12):1358-62. PubMed ID: 2095133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The bioequivalence of metoclopramide in two tablet formulations].
    Dobrev D; Berndt A; Oertel R; Richter K; Terhaag B; Gramatté T
    Arzneimittelforschung; 1995 Mar; 45(3):304-6. PubMed ID: 7741790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bioavailability of two commercial preparations of allopurinol tablets.
    Marcus M; Tse FL; Kleinberg SI
    Int J Clin Pharmacol Ther Toxicol; 1982 Jul; 20(7):302-5. PubMed ID: 7107081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bioequivalence of enteric coated tablet of Zhengqing Fengtongning].
    Zhang SH; Zhou YD; He HX
    Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(6):683-5. PubMed ID: 18590201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The relative bioavailability of paracetamol in suppositories in comparison to tablets].
    Blume H; Ali SL; Elze M; Krämer J; Scholz ME
    Arzneimittelforschung; 1996 Oct; 46(10):975-80. PubMed ID: 8992964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioequivalence of tolbutamide-containing tablet preparations.
    Barthel W; Böhm C; Hüller G; Haustein KO
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):43-6. PubMed ID: 9021442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The bioequivalence of a new amitriptyline tablet formulation in comparison with a reference preparation].
    Metzner JE; Buchberger D; Dilger C; Läuter J; Schmidt U
    Arzneimittelforschung; 1998 Nov; 48(11):1072-8. PubMed ID: 9850427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioequivalence evaluation of 2 different oral formulations of ciprofloxacin in healthy volunteers.
    Galicia I; Frias-Iniesta J; Carcas AJ; Soto A; Gomez E; Miranda E; Fernandez A; Montuenga C
    Int J Clin Pharmacol Ther; 1998 May; 36(5):282-5. PubMed ID: 9629993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The pharmacokinetics and bioequivalence of acipimox sustained-release tablets after a single and multiple oral administration in healthy dogs].
    Yang XG; Nie SF; Bai HJ; Zhang GJ; Pan WS
    Yao Xue Xue Bao; 2005 May; 40(5):457-61. PubMed ID: 16220793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative bioavailability of two formulations of azithromycin.
    Gulati R; Tripathi CD; Chandra D
    J Assoc Physicians India; 2000 Jun; 48(6):606-8. PubMed ID: 11273540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human bioequivalence study of a new nifedipine containing retard filmtablet after single and repeated administration.
    Klebovich I; Drabant S; Horvai G; Nemes KB; Grézal G; Horváth V; Hrabéczy-Páll A; Kocsi E; Cseh A; Balogh J; Farsang C
    Arzneimittelforschung; 1997 May; 47(5):598-603. PubMed ID: 9205772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.